Despite these measures, she remained significantly symptomatic with persistent hyperphagia and recurrent urticaria until genetic testing identified a pathogenic variant in BBS9, supporting a diagnosis of Bardet-Biedl Syndrome and ultimately guiding initiation of setmelanotide therapy. The gene discussed is BBS9; the disease is Bardet-Biedl syndrome.